Pre-made Dezamizumab benchmark antibody ( Whole mAb, anti-APCS therapeutic antibody, Anti-HEL-S-92n/PTX2/SAP Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-144

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-144 Category Tag

Product Details

Pre-Made Dezamizumab biosimilar, Whole mAb, Anti-APCS Antibody: Anti-HEL-S-92n/PTX2/SAP therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Dezamizumab biosimilar, Whole mAb, Anti-APCS Antibody: Anti-HEL-S-92n/PTX2/SAP therapeutic antibody

INN Name

Dezamizumab

Target

APCS

Format

Whole mAb

Derivation

Humanized

Species Reactivity

Human

CH1 Isotype

IgG1

VD LC

Kappa

Highest_Clin_Trial (Jan '20)

Phase-II

Est. Status

Discontinued

100% SI Structure

None

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2016

Companies

Pentraxin Therapeutics,GlaxoSmithKline

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

Amyloidosis

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

APCS

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide